Total Payments
$4,469
2023 Payments
$41.53
Companies
29
Transactions
329
Medicare Patients
2,126
Medicare Billing
$254,380

Payment Breakdown by Category

Food & Beverage$4,459 (99.8%)
Education$10.66 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,459 327 99.8%
Education $10.66 2 0.2%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $1,301 71 $0 (2020)
Novo Nordisk Inc $608.95 57 $0 (2020)
Janssen Pharmaceuticals, Inc $423.65 53 $0 (2020)
GlaxoSmithKline, LLC. $379.64 27 $0 (2021)
SANOFI-AVENTIS U.S. LLC $247.57 18 $0 (2020)
Astellas Pharma US Inc $192.38 12 $0 (2020)
Abbott Laboratories $177.01 10 $0 (2023)
Boehringer Ingelheim Pharmaceuticals, Inc. $131.94 9 $0 (2019)
PFIZER INC. $123.63 10 $0 (2020)
Merck Sharp & Dohme Corporation $109.18 9 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2023 $41.53 2 Abbott Laboratories ($41.53)
2021 $27.52 2 GlaxoSmithKline, LLC. ($14.13)
2020 $811.62 55 AstraZeneca Pharmaceuticals LP ($391.25)
2019 $1,270 91 AstraZeneca Pharmaceuticals LP ($400.18)
2018 $1,283 99 AstraZeneca Pharmaceuticals LP ($303.55)
2017 $1,036 80 AstraZeneca Pharmaceuticals LP ($206.28)

All Payment Transactions

329 individual payment records from CMS Open Payments — Page 1 of 14

Date Company Product Nature Form Amount Type
10/13/2023 Abbott Laboratories ETERNA (Device) Food and Beverage In-kind items and services $24.57 General
Category: Neuromodulation
07/10/2023 Abbott Laboratories PRODIGY (Device) Food and Beverage In-kind items and services $16.96 General
Category: Neuromodulation
08/24/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.39 General
Category: NEUROSCIENCE
04/14/2021 GlaxoSmithKline, LLC. SHINGRIX (Biological) Food and Beverage In-kind items and services $14.13 General
Category: VACCINES
11/19/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $18.02 General
Category: Diabetes
11/17/2020 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Food and Beverage In-kind items and services $14.47 General
Category: Respiratory
11/05/2020 Astellas Pharma US Inc MYRBETRIQ (Drug) Food and Beverage In-kind items and services $19.33 General
Category: UROLOGY
11/04/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $13.74 General
Category: Cardiovascular and Metabolism
10/28/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $19.68 General
Category: Diabetes
10/13/2020 AstraZeneca Pharmaceuticals LP BREZTRI AEROSPHERE (Drug) Food and Beverage In-kind items and services $12.29 General
Category: Respiratory
10/07/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.64 General
Category: Cardiovascular and Metabolism
09/30/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.13 General
Category: Cardiovascular and Metabolism
09/23/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $13.82 General
Category: Cardiovascular and Metabolism
09/16/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.22 General
Category: Cardiovascular and Metabolism
09/15/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $14.24 General
Category: Diabetes
09/09/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.62 General
Category: Cardiovascular and Metabolism
09/02/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.35 General
Category: Cardiovascular and Metabolism
08/25/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $13.73 General
Category: Diabetes
08/12/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $12.62 General
Category: Cardiovascular and Metabolism
08/11/2020 SANOFI-AVENTIS U.S. LLC SOLIQUA 100/33 (Biological) Food and Beverage In-kind items and services $11.23 General
Category: Endocrinology
07/30/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $15.91 General
Category: Diabetes
07/29/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.43 General
Category: Cardiovascular and Metabolism
07/15/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $11.04 General
Category: Cardiovascular and Metabolism
07/14/2020 PFIZER INC. CHANTIX (Drug), ELIQUIS Food and Beverage In-kind items and services $11.40 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
07/08/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $11.17 General
Category: Cardiovascular and Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 318 511 $144,685 $46,916
2022 8 441 901 $209,010 $66,461
2021 10 494 859 $210,185 $69,650
2020 20 873 1,282 $157,101 $71,352
Total Patients
2,126
Total Services
3,553
Medicare Billing
$254,380
Procedure Codes
44

All Medicare Procedures & Services

44 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 136 293 $58,455 $21,457 36.7%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 48 84 $24,660 $9,304 37.7%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 40 40 $20,670 $6,308 30.5%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 57 57 $29,355 $6,129 20.9%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 20 20 $8,100 $2,433 30.0%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 17 17 $3,445 $1,285 37.3%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 190 492 $95,940 $32,812 34.2%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 70 122 $32,940 $11,816 35.9%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 78 80 $41,200 $7,946 19.3%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 27 27 $13,905 $5,011 36.0%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 27 131 $13,100 $4,869 37.2%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 13 13 $5,265 $1,680 31.9%
99238 Hospital discharge day management, 30 minutes or less Facility 2022 20 20 $3,700 $1,304 35.2%
99217 Hospital observation care on day of discharge Facility 2022 16 16 $2,960 $1,024 34.6%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 181 469 $88,110 $32,084 36.4%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 67 105 $27,645 $10,320 37.3%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 79 81 $41,715 $8,150 19.5%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 35 35 $17,965 $6,687 37.2%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 29 29 $11,635 $3,790 32.6%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2021 27 56 $5,600 $1,999 35.7%
99238 Hospital discharge day management, 30 minutes or less Facility 2021 27 27 $4,910 $1,863 37.9%
99219 Hospital observation care, typically 50 minutes Facility 2021 14 14 $4,765 $1,800 37.8%
99225 Subsequent observation care, typically 25 minutes per day Facility 2021 16 23 $4,140 $1,576 38.1%
99217 Hospital observation care on day of discharge Facility 2021 19 20 $3,700 $1,380 37.3%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 185 354 $62,094 $27,025 43.5%

About Venessa Tan, MD, MPH

Venessa Tan, MD, MPH is a Student in an Organized Health Care Education/Training Program healthcare provider based in Stony Brook, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1780845669.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Venessa Tan, MD, MPH has received a total of $4,469 in payments from pharmaceutical and medical device companies, with $41.53 received in 2023. These payments were reported across 329 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,459).

As a Medicare-enrolled provider, Tan has provided services to 2,126 Medicare beneficiaries, totaling 3,553 services with total Medicare billing of $254,380. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.

Practice Information

Products in Payments

  • FARXIGA (Drug) $1,085
  • XARELTO (Drug) $390.07
  • Ozempic (Drug) $223.14
  • TOUJEO (Drug) $178.97
  • TRELEGY ELLIPTA (Drug) $169.30
  • XIFAXAN (Drug) $152.06
  • Saxenda (Drug) $130.70
  • Victoza (Drug) $121.95
  • AFREZZA (Drug) $106.97
  • JARDIANCE (Drug) $104.76
  • Myrbetriq (Drug) $94.98
  • Prolia (Biological) $80.58
  • FreeStyle Libre (Device) $75.26
  • PNEUMOVAX 23 (Biological) $73.19
  • Tresiba (Drug) $68.99
  • ADVAIR (Drug) $65.91
  • MYRBETRIQ (Drug) $64.29
  • BYDUREON (Drug) $63.01
  • CHANTIX (Drug) $61.71
  • ENTRESTO (Drug) $58.14

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Stony Brook